Pages that link to "Q37269265"
Jump to navigation
Jump to search
The following pages link to mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. (Q37269265):
Displaying 11 items.
- Impact of HPV infection on oral squamous cell carcinoma (Q37718270) (← links)
- Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer (Q38929870) (← links)
- Radiation alters the cargo of exosomes released from squamous head and neck cancer cells to promote migration of recipient cells (Q42172217) (← links)
- mTOR co-targeting strategies for head and neck cancer therapy (Q42363764) (← links)
- Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation (Q46238476) (← links)
- Mouse Models for Studying Oral Cancer: Impact in the Era of Cancer Immunotherapy. (Q53176144) (← links)
- HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner. (Q55223142) (← links)
- mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer (Q57450687) (← links)
- Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC (Q60923367) (← links)
- mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy (Q64274877) (← links)
- Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation (Q90965466) (← links)